Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Фільтри

(Clear all)

Genomic Instability in Alzheimer’s Disease and Related Disorders: a Single-Cell Approach

INSTALZ

Increasing evidence suggests that the genetic information in our bodies can vary from cell to cell. Such variation has also been found in the brain, although its consequences for brain function or disease remain largely unknown. In this project, we will study the role of genomic instability in Alzheimer's disease and related tauopathies. The...

Funding Programme
Start Date
End Date
Total Funding
€ 1 837 608
European Countries Involved

Get Ready For Activity – Ambient  Day Scheduling with Dementia

GREAT

Get Ready For Activity – persuasive ambiences is the modular application of ambient lighting, sound and scents research to create room ambiences for supporting people with dementia (PwD) and their caregivers in their daily activities and structure and positively influence erratic behaviour (depression and agitation) of PwD. The project aims to...

Funding Programme
Start Date
End Date
Total Funding
€ 3 000 000
European Countries Involved

Global Amyloid Mapping: Solving Amyloid Nucleation by Deep Mutagenesis

GLAM-Map

Amyloid fibrils form and precipitate in more than 50 incurable human diseases, including Alzheimer’s and Parkinson’s disease. All proteins may be able to form amyloids, at least under certain circumstances. However, aggregation is actually rare as the process of amyloid formation is controlled by a high kinetic barrier: protein sequences have to...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 008
European Countries Involved

Grammar and memory: Evidence from agrammatic aphasia and probable Alzheimer's disease in German, Italian and Greek

MemoGram

In Europe, there is an increasing number of people with neurological problems, such as probable Alzheimer’s disease (pAD) or aphasia, which often result in severe language and memory impairments. It has been argued that memory deficits contribute to the language problems brain-damaged populations face and, further, can predict these populations’...

Funding Programme
Start Date
End Date
Total Funding
€ 216 953
European Countries Involved

GSK-3 in neuronal plasticity and neurodegeneration: basic mechanisms and pre-clinical assessment

NEURO.GSK3

Neuronal circuits in mammalian brain act predominantly via excitatory synapses on dendritic spines. Formation of new spines in adult brain constitutes the structural basis of neuronal plasticity. The underlying molecular mechanisms remain largely unknown but depend essentially on kinase-dependent signalling pathways. Final formation of synapses on...

Funding Programme
Start Date
End Date
Total Funding
€ 5 082 027
European Countries Involved

Healthy Aging Through Internet Counselling in the Elderly

HATICE

Diabetes mellitus, hypertension, obesity, hypercholesterolemia, smoking and physical inactivity are common in elderly persons and are all associated with an increased risk of myocardial infarction, stroke and dementia. Efficacious treatments of these cardiovascular diseases are available, but in elderly patients with multiple cardiovascular...

Funding Programme
Start Date
End Date
Total Funding
€ 7 423 520
European Countries Involved

High Resolution Segmentation of Brain MR Images at 7 Teslas

HIRESBRAIN7T

The advent of magnetic resonance imaging (MRI) technology has brought us closer to understanding brain function in health and disease. With 7 Teslas high field MRI machines, pioneers of imaging physics have made possible in-vivo examination of the human brain at sub-millimetre scale. New imaging contrasts additionally offer rich information...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

High throughput mass spectrometry of single proteins in liquid environment

LIQUIDMASS

Although mass spectrometry has brought about major advancements in proteomics in the last decade, protein mass spectrometers still have important limitations. One fundamental limitation is that they require sample ionization, desorption into the gas phase and fragmentation, clearly leading to protein denaturation. Since relevant protein complexes...

Funding Programme
Start Date
End Date
Total Funding
€ 2 470 283
European Countries Involved

High-throughput vibrational fingerprinting by nanoplasmonics for disease biology

VIBRANT-BIO

Devastating diseases such as Alzheimer’s, Parkinson’s and various cancers are still without cures, continue to undermine the quality of life for millions of people and impose significant economic burdens. Misfolded toxic proteins constitute the microscopic basis of these diseases, but little is understood about their structure and biological...

Funding Programme
Start Date
End Date
Total Funding
€ 2 562 325
European Countries Involved

High-Throughput, High-Content Screening of human neuroectodermal organoids for innovative drug discovery in neurodegenerative diseases

3DMiniBrain

The goal of the 3D MiniBrain project is to establish and standardize the use of miniaturized human brain-like structures as a relevant three-dimensional (3D) testbed to decipher the roles of the main genetic risk factors for Alzheimer's disease and Parkinson's disease, according to original hypotheses obtained from our genetic studies. Minibrains...

Funding Programme
Start Date
End Date
Total Funding
€ 1 071 595
European Countries Involved

Hijacking small hydrophobic protein transport to deliver therapeutic agents to the central nervous system

SH-CNS-AM

Neurological disorders affect over 540 million individuals in Europe alone, yet effective treatments are limited, primarily due to the challenge of delivering therapeutic compounds across the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB). This project aims to develop a novel, virus-inspired technology that utilizes...

Funding Programme
Start Date
End Date
Total Funding
€ 263 393
European Countries Involved

Holographic super-resolution micro-endoscopy for in-vivo applications

LIFEGATE

Complexity of living matter currently poses the most significant barrier to modern in-vivo microscopy. Fuelled by various branches of life sciences, the race is now to increase the penetration depth of super-resolution imaging inside living organisms. Additionally, no high-resolution in-vivo imaging technique has ever been introduced into medical...

Funding Programme
Start Date
End Date
Total Funding
€ 1 997 973
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).